Aristea Therapeutics
San Diego, US · Founded 2018 · Delaware corporation · 5 known investors
Find your way into Aristea Therapeutics
Sign up to see every warm intro you have to Aristea Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aristea Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JM

James MackayExecutive
Board
LT
Loretta TseBoard director
KH

TA

CK
Ciara KennedyBoard director
Investors · 5
Fidelity InvestmentsreportedBoston
How we know: funding news · prnewswire.com · Not right? Tell us
Norwest Venture PartnersinferredMenlo Park · $10M – $30Mvia Tiba Aynechi · board
How we know: board seat on SEC Form D · Not right? Tell us
Novo HoldingsreportedCopenhagen · $1.1M – $54M
How we know: funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 2
Arena PharmaceuticalsTekla Capital Management, LLC
Funding
SEC filings, press & company announcements$141.1M disclosed across 3 rounds · 2018–2021
- $63MSeries BJul 2021 · 2 sources
Fidelity Management & Research Company, LLC. (lead), Arena Pharmaceuticals, Novo Holdings A/S, Tekla Capital Management, LLC
Source ↗ - $15MSeries ADec 2018 · 2 sourcesSource ↗
▶$63.1MraisedAug 2021 · 15 investors · BiotechnologyRule 506(b)
▶$63.1MraisedAug 2021 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Loretta TseDirector
- James MackayExecutive Officer, Director
- Kenneth HarrisonDirector
- Tiba AynechiDirector
- Ciara KennedyDirector
- Offering amount
- $63.1M
- Amount sold
- $63.1M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Aristea Therapeutics's investors?
- Aristea Therapeutics's investors include Fidelity Investments, Norwest Venture Partners, Novo Holdings.
- How much funding has Aristea Therapeutics raised?
- Aristea Therapeutics has disclosed $141.1M raised across 3 rounds.
- Where is Aristea Therapeutics headquartered?
- Aristea Therapeutics is headquartered in San Diego, US.
